Nucleic Acid Therapies have the potential to transform health
Harwell campus is a leading global hub for Nucleic Acid Therapies Research and Development and Manufacturing.
Home to organisations like Moderna, Catalent Pharma Solutions, the Rosalind Franklin Institute, and the NATA – Nucleic Acid Therapy Accelerator the future of NAT is looking bright.
We partnered with Fierce Pharma to create “Accelerating the Development of Nucleic Acid Therapies at Harwell Science and Innovation Campus” a new whitepaper looking at this exciting new technology, and you’ll also learn:
– About unique resources and collaborations available at Harwell and how they are expediting NAT research
– About the Rosalind Franklin Institute’s multidisciplinary teams and cutting-edge technology that are driving scientific breakthroughs
– How the Nucleic Acid Therapy Accelerator is propelling NAT technology
– Why Moderna chose Harwell as the location for its new UK Centre of Excellence
Click the button below to request your copy of “Accelerating the Development of Nucleic Acid Therapies at Harwell Science and Innovation Campus” now.